ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,881.01
-0.30%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Senesco Technologies (SNT)

  7. Senesco Technologies (SNT) Noticias

SNT

Senesco (SNT)

Senesco Technologies
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:SNT
FechaHoraFuenteTítuloSímboloCompañía
23/11/201211:50Edgar (US Regulatory)(25-NSE)AMEX:SNTSenesco Technologies
23/11/201211:50Edgar (US Regulatory)(25-NSE)AMEX:SNTSenesco Technologies
21/11/201210:43Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)AMEX:SNTSenesco Technologies
21/11/201210:42Edgar (US Regulatory)Current report filing (8-K)AMEX:SNTSenesco Technologies
21/11/201210:42Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SNTSenesco Technologies
16/11/201216:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
16/11/201216:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
16/11/201216:20Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)AMEX:SNTSenesco Technologies
14/11/201213:58Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:SNTSenesco Technologies
14/11/201213:58Edgar (US Regulatory)Quarterly Report (10-q)AMEX:SNTSenesco Technologies
26/10/201205:37Edgar (US Regulatory)Amended Annual Report (10-K/A)AMEX:SNTSenesco Technologies
28/09/201210:58Edgar (US Regulatory)Annual Report (10-K)AMEX:SNTSenesco Technologies
09/07/201216:23PR Newswire (US)Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.comAMEX:SNTSenesco Technologies
02/07/201214:51Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:SNTSenesco Technologies
12/06/201208:00PR Newswire (US)NYSE Companies' and NASDAQ Companies' June 7th Investor Presentations Now Available at RetailInvestorConferences.comAMEX:SNTSenesco Technologies
06/06/201212:30PR Newswire (US)Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on June 7thAMEX:SNTSenesco Technologies
05/06/201217:43PR Newswire (US)NYSE Companies and NASDAQ Companies Meet to Webcast Live, June 7th, at RetailInvestorConferences.comAMEX:SNTSenesco Technologies
04/06/201207:30Business WireSenesco Provides SNS01-T Update on Phase 1b/2a Multiple Myeloma TrialAMEX:SNTSenesco Technologies
30/05/201209:00Business WireSenesco’s SNS01-T to be Presented During Poster Session at 2012 Annual Meeting of the American Society of Clinical OncologyAMEX:SNTSenesco Technologies
23/05/201207:30Business WireSenesco’s SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple MyelomaAMEX:SNTSenesco Technologies
15/05/201207:30Business WireSenesco Technologies Reports Fiscal 2012 Third Quarter ResultsAMEX:SNTSenesco Technologies
14/05/201207:30Business WireSenesco to Present SNS01-T, an eIF5A-based Nanoparticle in a Phase 1b/2a Trial to Treat Multiple Myeloma, is Effective in Mod...AMEX:SNTSenesco Technologies
01/05/201207:30Business WireCombination of Lenalidomide and SNS01-T Effective in Cancer ModelAMEX:SNTSenesco Technologies
24/04/201213:08Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:SNTSenesco Technologies
19/03/201213:26Edgar (US Regulatory)Statement of Ownership (SC 13G)AMEX:SNTSenesco Technologies
12/03/201213:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:SNTSenesco Technologies
07/03/201207:30Business WireSenesco Adds Additional Clinical Site to Evaluate SNS01-T in Multiple MyelomaAMEX:SNTSenesco Technologies
02/03/201207:42Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)AMEX:SNTSenesco Technologies
02/03/201207:30Business WireSenesco Announces Additional $1.0 Million Equity FinancingAMEX:SNTSenesco Technologies
01/03/201207:30Business WireSenesco Adds Second Clinical Site to Evaluate SNS01-T in Multiple MyelomaAMEX:SNTSenesco Technologies
 Showing the most relevant articles for your search:AMEX:SNT

Su Consulta Reciente

USOTC
LNDRS
Landa App (GM)
EU
3440T
3440T
USOTC
RRRUF
R and R Real Estate Inve... (PK)
USOTC
MTNOY
MTN (PK)
NASDAQ
AAXOUXX
JPMorgan Chase Financial...
EU
G021T
G021T
USOTC
RSBIS
RSE Archive (GM)
NASDAQ
AAWNHXX
Jpmorgan Chase Financial...
ASX
INE
India Equities Fund
LSE
96BK
Fed Uae 31 A
TSX
9343
Ibis
BIT
EMLA
SPDR Bloomberg Barclays ...
BOV
EZTC3F
EZTEC ON
NASDAQ
OTEX
Open Text
EU
SNAN
SNCF SNCFFRN22JUN2042
LATK
OXMUSDT
OXM Protocol
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados